AlphaVax Overview
- Year Founded
-
1997
- Status
-
Acquired/Merged
- Employees
-
9
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$20M
AlphaVax General Information
Description
Developer of vaccines for cancer immunotherapy intended for anti-infective and anti-cancer vaccines. The company engages a proprietary RNA replicon vector platform derived from attenuated strains of the alphavirus to treat diseases such as influenza, cytomegalovirus, HIV, prostate cancer, and breast cancer, among others, enabling healthcare providers to have access to novel therapies to better treat diseases in patients.
Contact Information
Website
www.alphavax.com(Operating Subsidiary)
Corporate Office
- 2 Triangle Drive
- Po Box 110307, Research Triangle Park
- Durham, NC 27709-0307
- United States
Corporate Office
- 2 Triangle Drive
- Po Box 110307, Research Triangle Park
- Durham, NC 27709-0307
- United States
AlphaVax Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Merger/Acquisition | 29-Dec-2008 | $20M | Completed | Clinical Trials - Phase 2 | ||
| 9. Grant | 10-Jul-2007 | Completed | Clinical Trials - Phase 2 | |||
| 8. Later Stage VC (Series E) | 05-Feb-2007 | Completed | Clinical Trials - Phase 2 | |||
| 7. Grant | 19-Oct-2005 | Completed | Clinical Trials - Phase 2 | |||
| 6. Grant | 17-Nov-2004 | Completed | Clinical Trials - Phase 2 | |||
| 5. Later Stage VC | 06-Jan-2004 | Completed | Clinical Trials - Phase 2 | |||
| 4. Grant | 21-Oct-2003 | Completed | Clinical Trials - Phase 2 | |||
| 3. Later Stage VC (Series C) | 03-Apr-2002 | Completed | Clinical Trials - Phase 2 | |||
| 2. Accelerator/Incubator | 01-Jan-2002 | $8.2M | Completed | Clinical Trials - Phase 2 | ||
| 1. Early Stage VC (Series B) | 28-Feb-2001 | $8.2M | $8.2M | Completed | Clinical Trials - Phase 2 |
AlphaVax Comparisons
Industry
Financing
Details
AlphaVax Competitors (73)
One of AlphaVax’s 73 competitors is Aro Biotherapeutics, a Venture Capital-Backed company based in Philadelphia, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Aro Biotherapeutics | Venture Capital-Backed | Philadelphia, PA | ||||
| Mabworks Biotech | Venture Capital-Backed | Beijing, China | ||||
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
| Symphogen | Formerly VC-backed | Ballerup, Denmark | ||||
| Gracell | Formerly VC-backed | Shanghai, China |
AlphaVax Patents
AlphaVax Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2010234362-A1 | Alphavirus replicon particles expressing trp2 | Active | 08-Apr-2009 | ||
| AU-2010234362-B2 | Alphavirus replicon particles expressing trp2 | Active | 08-Apr-2009 | ||
| AU-2015249175-A1 | Alphavirus replicon particles expressing trp2 | Inactive | 08-Apr-2009 | ||
| AU-2017276161-A1 | Alphavirus replicon particles expressing trp2 | Active | 08-Apr-2009 | ||
| AU-2017276161-B2 | Alphavirus replicon particles expressing trp2 | Active | 08-Apr-2009 |
AlphaVax Signals
AlphaVax Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Institute Of Allergy and Infectious Diseases | Government | |||
| National Institute for Allergy and Infectious Disease | Government | |||
| Springboard Enterprises | Accelerator/Incubator |
AlphaVax FAQs
-
When was AlphaVax founded?
AlphaVax was founded in 1997.
-
Where is AlphaVax headquartered?
AlphaVax is headquartered in Durham, NC.
-
What is the size of AlphaVax?
AlphaVax has 9 total employees.
-
What industry is AlphaVax in?
AlphaVax’s primary industry is Drug Discovery.
-
Is AlphaVax a private or public company?
AlphaVax is a Private company.
-
What is the current valuation of AlphaVax?
The current valuation of AlphaVax is .
-
What is AlphaVax’s current revenue?
The current revenue for AlphaVax is .
-
How much funding has AlphaVax raised over time?
AlphaVax has raised $32.8M.
-
Who are AlphaVax’s investors?
National Institute Of Allergy and Infectious Diseases, National Institute for Allergy and Infectious Disease, and Springboard Enterprises have invested in AlphaVax.
-
Who are AlphaVax’s competitors?
Aro Biotherapeutics, Mabworks Biotech, Inovio Pharmaceuticals, Symphogen, and Gracell are some of the 73 competitors of AlphaVax.
-
When was AlphaVax acquired?
AlphaVax was acquired on 29-Dec-2008.
-
Who acquired AlphaVax?
AlphaVax was acquired by Novartis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process